Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$75.2K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| ABOS |
| Acumen Pharmaceuticals,… |
| MEXER |
| 13,040 |
| $1.07 |
| $14K |
| +36.7% |
| Open the original filing on SEC.gov |
| Jun 16 | ABOS | Acumen Pharmaceuticals,… | SSELL | 12,800 | $2.33 | $29.8K | -26.5% | Open the original filing on SEC.gov |
| Jun 15 | ABOS | Acumen Pharmaceuticals,… | MEXER◆ | 6,460 | — | — | — | Open the original filing on SEC.gov |
| Jun 15 | ABOS | Acumen Pharmaceuticals,… | SSELL | 6,460 | $2.35 | $15.1K | -11.8% | Open the original filing on SEC.gov |
| Jun 15 | ABOS | Acumen Pharmaceuticals,… | MEXER | 6,460 | $1.07 | $6.9K | +13.4% | Open the original filing on SEC.gov |
| Jun 3 | ABOS | Acumen Pharmaceuticals,… | AGRANT◆ | 53,250 | — | — | — | Open the original filing on SEC.gov |
| Jun 3 | ABOS | Acumen Pharmaceuticals,… | AGRANT | 35,500 | — | — | +277.3% | Open the original filing on SEC.gov |
| May 19 | PASG | Passage BIO, Inc. | AGRANT◆ | 10,539 | — | — | — | Open the original filing on SEC.gov |